ZMZeynep Mutlu

Zeynep Mutlu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zeynep Mutlu has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Integrated Bioinformatics Identification and Multi-Dimensional Characterization of Diagnostic Hub Genes in Colorectal Cancer

    by Zeynep Mutlu Coskun, Muhammet Coskun, Saime Sezer Sondas

    Colorectal cancer (CRC) motivates the investigation of complementary molecular markers, although tissue-transcriptomic discrimination does not by itself establish early-detection performance. We identified differentially expressed genes in 98 paired CRC and adjacent-normal samples from GSE44076 using gene-level limma analysis (|log2FC| > 1; Benjamini–Hochberg-adjusted p < 0.05), screened candidates through a STRING protein–protein interaction network, and evaluated diagnostic performance with independent validation in GSE9348. Functional characterization included MSigDB KEGG_LEGACY over-representation analysis and preranked GSEA, immune-marker correlations, mRNA stemness index analysis, exploratory topology-filtered cysteine assessment, exploratory TCGA-COAD prognostic modelling, and literature-curated single-cell contextualization. Seven candidates—AQP8, CA7, GUCA2A, GUCA2B, BEST4, TMIGD1, and OTOP2—showed AUC values of 0.986–0.995 in the discovery cohort; five genes showed AUC values of 0.999–1.000 in the retrospective GSE9348 tissue cohort. AQP8 and GUCA2B showed weak nominal inverse correlations with mRNAsi that did not remain significant after correction across six tests (BH-FDR = 0.078), and the genes were predominantly associated with differentiated colonic epithelial lineages. The exploratory prognostic model was non-significant. These results identify seven tissue-transcriptomic candidates with strong dataset-specific discriminative performance and provide a multidimensional biological framework warranting experimental validation and prospective clinical evaluation.

  • Origanum Sipyleum Methanol Extract in Combination with Ponatinib Shows Synergistic anti-Leukemic Activities on Chronic Myeloid Leukemia Cells

    by Cagla Kayabasi, Sunde Yilmaz Susluer, Tugce Balci Okcanoglu, Besra Ozmen Yelken, Zeynep Mutlu, Bakiye Goker Bagca, Cansu Caliskan Kurt, Guray Saydam, Cenk Durmuskahya, Husniye Kayalar, et al.

    Origanum sipyleum is used in folk medicine due to its anti-inflammatory, antimicrobial, and antioxidant properties. Ponatinib, an effective tyrosine kinase inhibitor in the treatment of chronic myeloid leukemia (CML), has severe side effects. Thus, we aimed to determine a novel herbal combination therapy that might not only increase the anti-leukemic efficacy but also reduce the dose of ponatinib in targeting CML cells. Origanum sipyleum was extracted with methanol (OSM), and secondary metabolites were determined by phytochemical screening tests. The cytotoxic effects of OSM on K562 cells were measured by WST-1 assay. Median-effect equation was used to analyze the combination of ponatinib and OSM (p-OSM). Apoptosis, proliferation, and cell-cycle were investigated by flow-cytometry. Cell-cycle-related gene expressions were evaluated by qRT-PCR. OSM that contains terpenoids, flavonoids, tannins, and anthracenes exhibited cytotoxic effects on K562 cells. The median-effect of p-OSM was found as synergistic; OSM reduced the ponatinib dose ∼5-fold. p-OSM elevated the apoptotic and anti-proliferative activity of ponatinib. Consistently, p-OSM blocked cell-cycle progression in G0/G1, S phases accompanied by regulations in TGFB2, ATR, PP2A, p18, CCND1, CCND2, and CCNA1 expressions. OSM enhanced the anti-leukemic activity of ponatinib synergistically via inducing apoptosis, suppressing proliferation, and cell-cycle. As a result, OSM might offer a potential strategy for treating patients with CML.


  • Ponatinib Targets Breast Cancer Cells by Regulating miRNA Expressions

    by Çağla Kayabaşi, Sunde Yilmaz Süslüer, Tuğçe BALCI OKCANOĞLU, Besra Özmen Yelken, Zeynep Mutlu, Cansu Çalişkan Kurt, Bakiye Goker Bagca, Çığır Bi̇ray Avci, Cumhur Gündüz

    Meme kanseri kadınlarda en yaygın gözlenen kanser türüdür. Mevcut tedavilerin düşük seçicilik ya da zamanla oluşan ilaç direnci gibi eksiklerini giderebilecek yeni stratejilerin belirlenmesine ihtiyaç vardır. Çalışmamızda, çoklu hedefli bir tirozin kinaz inhibitörü olan ponatinibin meme kanseri hücreleri üzerindeki anti-kanser etkisini değerlendirmeyi ve ponatinib yanıtında yer alan miRNA'ların biyoinformatik yaklaşım ile sinyal yolaklarındaki potansiyel işlevini tanımlamayı hedefledik. Bu amaçla, MCF-7 hücrelerinde ponatinibin sitotoksik etkileri xCELLigence ile gerçek-zamanlı olarak belirlendi. Ponatinib uygulaması sonrasında apoptoz, proliferasyon hızı, hücre döngüsündeki değişimler akım sitometriyle, miRNA'ların ifadelerindeki düzenlenmeler qRT-PCR ile değerlendirildi. İfadelerinde anlamlı değişim belirlenen miRNA’ların ilişkili olduğu olası mRNA’lar ve sinyal yolakları KEGG yolak analizi ile tanımlandı. Ponatinibin MCF-7 hücreleri üzerinde sitotoksik etkiye sahip olduğu (IC50: 4,59 μM) belirlendi. Ponatinib uygulaması ile MCF-7 hücrelerinde anlamlı olarak apoptozun indüklendiği, proliferasyonun baskılandığı ve hücre döngüsünün G0/G1, S evrelerinde durakladığı belirlendi. Ayrıca, let-7a-5p, miR-29a-3p, miR-7-5p, miR-125b-5p, miR-212-3p ifadelerinde artış (p

  • Open Access

    Pre-service Social Studies Teachers' Opinions on Using Comic Books in Social Studies Teaching

    by Ayten Kiriş Avaroğulları, Zeynep Mutlu

    In the age of technology which is ever changing and developing, not only the technologies but also the generations have different characteristics. Therefore, the methods and the materials used in teaching are changing as well. Today, comic books are one of the materials that are used for bringing students' attention into the class and motivating their active participation in the class. This study examines the opinions of the 4th-grade pre-service social studies teachers, who are educated in preparing comic books, on designing and using comic books in social studies teaching. This research is a descriptive study. The study was carried out in the 2018-2019 school year with the pre-service social studies teachers, who continue their education at a university in western Turkey. The practice of the preparation of comic book panels was carried out for six weeks. Before and after the comic book preparation practices, participants took surveys with open-ended questions that were provided by the researchers. The data acquired from the open-ended survey forms are used for content analysis. According to the findings obtained throughout the research, it has been concluded that the fourth-grade pre-service social studies teachers, who are trained in preparing comic book panels, have positive views on preparing and using comic books in social studies teaching. Several propositions are made in light of these findings.


  • Zoledronic acid induces apoptosis via stimulating the expressions of ERN1, TLR2, and IRF5 genes in glioma cells

    by Cigir Biray Avci, Cansu Caliskan Kurt, Burcu Erbaykent Tepedelen, Ozgun Ozalp, Bakiye Goker, Zeynep Mutlu, Yavuz Dodurga, Levent Elmas, Cumhur Gunduz

    Glioblastoma multiforme (GBM) is the most common and aggressive brain tumor that affects older people. Although the current therapeutic approaches for GBM include surgical resection, radiotherapy, and chemotherapeutic agent temozolomide, the median survival of patients is 14.6 months because of its aggressiveness. Zoledronic acid (ZA) is a nitrogen-containing bisphosphonate that exhibited anticancer activity in different cancers. The purpose of this study was to assess the potential effect of ZA in distinct signal transduction pathways in U87-MG cells. In this study, experiments performed on U87-MG cell line (Human glioblastoma-astrocytoma, epithelial-like cell line) which is an in vitro model of human glioblastoma cells to examine the cytotoxic and apoptotic effects of ZA. IC50 dose of ZA, 25 μM, applied on U87-MG cells during 72 h. ApoDIRECT In Situ DNA Fragmentation Assay was used to investigate apoptosis of U87MG cells. The quantitative reverse transcription polymerase chain reaction (qRT-PCR) (LightCycler480 System) was carried out for 48 gene expression like NF-κB, Toll-like receptors, cytokines, and inteferons. Our results indicated that ZA (IC50 dose) increased apoptosis 1.27-fold in U87MG cells according to control cells. According to qRT-PCR data, expression levels of the endoplasmic reticulum-nuclei-1 (ERN1), Toll-like receptor 2 (TLR2), and human IFN regulatory factor 5 (IRF5) tumor suppressor genes elevated 2.05-, 2.08-, and 2.3-fold by ZA, respectively, in U87MG cells. Our recent results indicated that ZA have a key role in GBM progression and might be considered as a potential agent in glioma treatment.


  • Open Access

    Sequencing of mutations in the serine/threonine kinase domain of the bone morphogenetic protein receptor type 2 gene causing pulmonary arterial hypertension

    by Zeynep Mutlu, Meral Kayikcioglu, Sanem Nalbantgil, Ozcan Vuran, Hatice Kemal, Nesrin Mogulkoc, Biray Erturk, Huseyin Onay, Zuhal Eroglu, Hakan Kulturuay

    Anadolu Kardiyoloji Dergisi, Anadolu Kardiyol Derg, The Anatolian Journal of Cardiology, Anatol J Cardiol, Cardiology, Cardiovascular Medicine, Surgery, Pediatric Cardiology, Angiology


  • Ruxolitinib induces autophagy in chronic myeloid leukemia cells

    by Bakiye Goker Bagca, Ozgun Ozalp, Cansu Caliskan Kurt, Zeynep Mutlu, Guray Saydam, Cumhur Gunduz, Cigir Biray Avci

    Ruxolitinib is the first agent used in myelofibrosis treatment with its potent JAK2 inhibitory effect. In this novel study, we aimed to discover the anti-leukemic effect of ruxolitinib in K-562 human chronic myeloid leukemia cell line compared to NCI-BL 2171 human healthy B lymphocyte cell line. Cytotoxic effect of ruxolitinib was determined by using WST-1 assay. IC50 values for K-562 and NCI-BL 2171 cell lines were defined as 20 and 23.6 μM at the 48th hour, respectively. Autophagic effects of ruxolitinib were detected by measuring LC3B-II protein formation. Ruxolitinib induced autophagic cell death in K-562 and NCI-BL 2171 cell lines 2.11- and 1.79-fold compared to control groups, respectively. To determine the autophagy-related gene expression changes, total RNA was isolated from K-562 and NCI-BL 2171 cells treated with ruxolitinib and untreated cells as control group. Reverse transcription procedure was performed for cDNA synthesis, and gene expressions were shown by RT-qPCR. Ruxolitinib treatment caused a notable decrease in expression of AKT, mTOR, and STAT autophagy inhibitor genes in K-562 cells, contrariwise control cell line. Ruxolitinib is a promising agent in chronic myeloid leukemia treatment by blocking JAK/STAT pathway known as downstream of BCR-ABL and triggering autophagy. This is the first study that reveals the relationship between ruxolitinib and autophagy induction.


    • 24 December 2014
      • Vol. 19  (4) , 992-8

    Synergistic effect of ponatinib and epigallocatechin-3-gallate induces apoptosis in chronic myeloid leukemia cells through altering expressions of cell cycle regulatory genes.

    by Bakiye Goker, Cansu Caliskan, Hasan Onur Caglar, Cagla Kayabasi, Tugce Balci, Burcu Erbaykent Tepedelen, Duygu Aygunes, Sunde Yilmaz Susluer, Zeynep Mutlu, Nur Selvi Gunel, et al.

    Ponatinib (P) has been used for the treatment of chronic myeloid leukemia (CML) and it is known that inhibition of BCR-ABL fusion protein by ponatinib induces apoptosis of CML cells. Epigallocatechin-3-gallate (EGCG), which is a polyphenol in green tea, induces apoptosis in different types of cancer cells. The purpose of this study was to determine the cytotoxic and apoptotic effects of ponatinib and EGCG combination in K562 CML cell line. This study also aimed to detect alterations of the expression levels of cell cycle-regulation related genes after ponatinib and EGCG combination in K562 CML cell line. The cytotoxic effects of the compounds on K562 cells were determined in a time-and dose-dependent manner by using WST-1 analysis. The combination index (CI) isobologram was used to analyze the data. Apoptotic effects of P-EGCG were defined by flow cytometry and gene expressions were detected by RT-qPCR. IC50values of ponatinib and EGCG were 87.13 nM and 50μM, respectively. CI value of the P-EGCG was 0.658 and the combination showed synergistic effect (ED90 value: 28.39 nM ponatinib, 117.12 μg/ml EGCG). Ponatinib, EGCG and P-EGCG induced apoptosis compared to control cells. CyclinD1 and CDC25A were downregulated by P-EGCG by 2.49 and 2.63-fold, respectively. TGF-β2 was upregulated by 4.57-fold. EGCG possesses cytotoxic and apoptotic properties and may cooperate with the growth inhibiting activity of ponatinib synergistically against CML cells. P-EGCG mediated apoptosis might be associated with upregulation of TGF-β2 gene and downregulation of cyclinD1 and CDC25A genes.


  • Identification of Y chromosome microdeletions in infertile Turkish men

    by Ali Şahin Küçükaslan, Vildan Bozok Çetintaş, Raşit Altıntaş, Aslı Tetik Vardarlı, Zeynep Mutlu, Murat Ulukuş, Bülent Semerci, Zuhal Eroğlu

    Objective: The aim of this study was to determine the frequencies of Y chromosome microdeletions in infertile azoospermic and oligozoospermic Turkish men and in healthy control subjects. Material and methods: Sixty-four azoospermic and 51 oligozoospermic patients with infertility and 70 healthy men who had a child naturally without assisted reproductive technology were included in this study. DNA was extracted from peripheral blood samples collected from the patients. Following multiplex PCR performed with 15 different primer sequences, Y chromosome AZFa, AZFb, AZFc and AZFd region microdeletions were determined by agarose gel electrophoresis. Results: Y chromosome microdeletions were detected in 8 (12.5%) patients in the azoospermia group and 3 (5.9%) patients in the oligozoospermia group. The overall prevalence of Y chromosome microdeletions in infertile men was 9.6%. Y chromosome microdeletions were not found in the healthy control group. Among the infertile cases, there were 4 (3.48%) AZFa, 2 (1.74%) AZFb, 3 (2.61%) AZFc and 7 (6.09%) AZFd region microdeletions. Conclusion: The presence of Y chromosome microdeletions among azoospermic and oligozoospermic infertile males suggests that routine genetic testing and genetic counseling prior to the use of assisted reproduction techniques are necessary.